Balance of tumor necrosis factor alpha and interleukin-10 in a buccal infection in a streptozotocin-induced diabetic rat model

Cytokine

Volumn 24, Issue 4, 2003, Pages 143-149

  Furudoi, Shungo ^a   Yoshii, Takashi ^a,b   Komori, Takahide ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Dentistry   (Japan)

Author keywords

Buccal abscess; Diabetic rat model; Interleukin 10 (IL 10); Streptozotocin; Tumor necrosis factor alpha (TNF )

Indexed keywords

CARRAGEENAN; INTERLEUKIN 10; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATORY CELL; INJECTION SITE; MOUTH ABSCESS; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; STREPTOZOCIN DIABETES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES;

EID: 0142027224     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.011     Document Type: Article

References (38)

1. Bagdade J.D., Root R.K., Bulger R.J. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 23:1974;9-15.
2. Robertson H.D., Polk H.C. Jr. The mechanism of infection in patients with diabetes mellitus. A review of leukocyte malfunction. Surgery. 75:1974;123-128.
3. Saiki O., Negoro S., Tsuyuguchi I., Yamamura Y. Depressed immunological defence mechanisms in mice with experimentally induced diabetes. Infect Immun. 28:1980;127-131.
4. Mowat A.G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 284:1971;621-627.
5. Gamble J.R., Harlan J.M., Klebanoff S.J., Vadas M.A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 82:1985;8667-8671.
6. Hickey M.J., Issekutz A.C., Reinhardt P.H., Fedorak R.N., Kubes P. Endogeneous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res. 83:1998;1124-1131.
7. Dinarello C.A. The biology of interleukin-1 and comparison to tumor necrosis factor. Immunol Lett. 16:1987;227-231.
8. Le J., Vilcek J. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 56:1987;234-248.
9. Kolls J.K., Lei D., Nelson S., Summer W.R., Greenberg S., Beutler B. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defence. J Infect Dis. 171:1995;570-575.
10. Gosselin D., DeSanctis J., Boule M., Skamene E., Matouk C., Radzioch D. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun. 63:1995;3272-3278.
11. Brieland J.K., Remick D.G., Freeman P.T., Hurley M.C., Fantone J.C., Engleberg N.C. In vivo regulation of replicative Legionella pneumoniae lung infection by endogeneous tumor necrosis factor alpha and nitric acid. Infect Immun. 63:1995;3253-3258.
12. van der Poll T., Keogh C.V., Buurman W.A., Lowry S.F. Passive immunization against tumor necrosis factor-α impairs host defence during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 155:1997;603-608.
13. Dayer J.M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 162:1985;2163-2168.
14. Brouckaert P., Fiers W. Tumor necrosis factor and the systemic inflammatory response syndrome. Curr Top Microbiol Immunol. 216:1996;167-187.
15. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 7:1996;93-124.
16. Fiorentino D., Bond M., Mosmann T. Two types of mouse helper T cells. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 170:1989;2081-2095.
17. Fiorentino D., Zlotnik A., Mosmann T., Howard M., O'Garra A. Il-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
18. Moor K.W., O'Garra A., de Waal Malefyt R., Vieria P., Mosmann T.R. Interleukin 10. Annu Rev Immunol. 11:1993;165-190.
19. Stordeur P., Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecularaspects. Int Rev Immunol. 16:1998;501-522.
20. Bone R.C. Sir Issac Newton, sepsis, and CARS. Crit Care Med. 24:1996;1125-1128.
21. Ohtsuka Y., Yoshii T., Nakao K., Shimada K. Experimental study on general conditions related to outbreak of oral and maxillofacial infections after inoculation of S. pyogenes S-8 - buccal abscess induced by carageenin in leukocytopenic rats. Oral Ther Pharmacol. 17:1998;10-17.
22. Lewis M.A., MacFarlane T.W., McGowan D.A. A microbiological and clinical review of the acute dentoalveolar abscess. Br J Oral Maxillofac Surg. 28:1990;359-366.
23. Tan A.M., Ferrante A., Goh D.H., Roberton D.M., Cripps A.W. Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. Radiat Res. 37:1995;155-159.
24. Huhn R.D., Pennline K., Radwanski E., Clarke L., Sabo R., Cutler D.L. Effects of single intravenous doses of recombinant human interleukin-10 on subjects of circulating leukocytes in humans. Immunopharmacology. 41:1999;109-117.
25. Laichalk L.L., Danforth J.M., Standiford T.J. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol. 15:1996;181-187.
26. Oswald I.P., Wynn T.A., Sher A., James S.L. Interleukin-10 inhibits microbicidal activity by blocking endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon-γ- induced activation. Proc Natl Acad Sci U S A. 89:1992;8676-8680.
27. van der Poll T., Marchant A., Buurman W.A., Berman L., Keogh C.V., Lazarus D.D., et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 155:1995;5397-5401.
28. Gudmundsson G., Bosch A., Davidson B.L., Berg D.J., Hunninghake G.W. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Repir Cell Mol Biol. 19:1998;812-818.
29. Armstrong L., Millar A.B. Relative production of tumor necrosis factor α and interleukin-10 in adult respiratory distress syndrome. Thorax. 52:1997;442-446.
30. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 152:1995;2111-2118.
31. Wanidworanun C., Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol. 151:1993;6853-6861.
32. Platzer C., Meisel C., Vogt K., Platzer M., Volk H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol. 7:1995;517-523.
33. Westwick J.K., Weitzel C., Minden A., Karin M., Brenner D.A. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-jun kinase. J Biol Chem. 269:1994;26396-26401.
34. Nichols W.K., Vann L.L., Spellman J.B. Streptozotosin effects on T lymphocytes and bone marrow cells. Clin Exp Immunol. 46:1981;627-632.
35. Chappel C.I., Chappel W.R. The discovery and development of the BB rat colony: an animal model of spontaneous diabetes mellitus. Metabolism. 32:1983;8-10.
36. Rakieten N., Rakieten M., Nadkarni M.V. Studies on the diabetogenic action of streptozotosin. Cancer Chemother Rep. 29:1963;91-98.
37. Nishigaki A., Noma H., Kakizawa T. The relations between doses of streptozotocin and pathosis in the induced diabetes mellitus. Shika Gakuho. 89:1989;639-662.
38. Yoshii T. An experimental study on penetration of antibiotics to inflammatory tissue. Kobe J Med Sci. 53:1992;157-180.